alphatau.com (DRTS) - כלל התחייבויות החוב של החברה

Alpha Tau Medical Ltd. (DRTS) is developing an innovative method for combating tumors via diffusion therapy. However, a narrow profile and challenges regarding the implementation of technologies in clinics are hindering financial growth, while the individual debt metric stands at 0.01. The market price, as confirmed by the chart, reflects the dynamics of the Israeli developer, which is betting on establishing its own laboratories in the US and conducting independent global research without utilizing M&A transactions.

This indicator assesses the level of debt load, determining the financial stability and bankruptcy risk of the issuer. The dynamics of total borrowings allow for tracking the balance between leverage and business growth rates. The metric aggregates all bond and loan obligations to analyze leverage. Debt control is critical for Alpha Tau Medical Ltd. (DRTS) due to geopolitical instability in Israel. Diversification of clinical bases mitigates these risks.